These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9119932)

  • 41. High-dose therapy in multiple myeloma.
    Harousseau JL; Attal M
    Hematol J; 2003; 4(3):163-70. PubMed ID: 12764348
    [No Abstract]   [Full Text] [Related]  

  • 42. Allogeneic bone marrow transplantation for therapy-related acute lymphocytic leukemia after autologous hematopoietic stem cell transplantation for multiple myeloma.
    Konishi Y; Tada K; Nishi K; Imada K
    Ann Hematol; 2016 Oct; 95(10):1739-40. PubMed ID: 27473192
    [No Abstract]   [Full Text] [Related]  

  • 43. Myeloablative chemotherapy and stem cell transplantation in myeloma or primary amyloidosis with renal involvement.
    Gertz MA; Leung N; Lacy MQ; Dispenzieri A
    Kidney Int; 2005 Oct; 68(4):1464-71. PubMed ID: 16164623
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of tandem stem cell transplantation for multiple myeloma patients.
    Martino M; Recchia AG; Fedele R; Neri S; Vincelli ID; Moscato T; Gentile M; Morabito F
    Expert Opin Biol Ther; 2016; 16(4):515-34. PubMed ID: 26698133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of myeloma: role of intensive treatments].
    Fermand JP; Ravaud P
    Presse Med; 1997 Apr; 26(11):521-4. PubMed ID: 9137386
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Acquired factor X deficiency developed four years after autologous transplantation in a patient with multiple myeloma associated with systemic AL amyloidosis].
    Takemura T; Fukatsu Y; Nagata Y; Asahina A; Yokota D; Hirano I; Yagyu T; Ono T; Katsumi A; Ohnishi K
    Rinsho Ketsueki; 2014 May; 55(5):558-62. PubMed ID: 24881922
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hematopoietic stem cell autografts in support of myeloablative therapy for multiple myeloma.
    Barlogie B; Jagannath S; Vesole D; Tricot G
    J Hematother; 1994; 3(2):149-53. PubMed ID: 7922016
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous stem cell support.
    Johnsen HE; Björkstrand B; Carlson K; Gruber A; Blystad A; Fast A; Boesen AM; Björkholm M; Sallerfors B; Ruutu T; Carneskog J; Malm A; Geisler C; Lehtinen M; Schrøder H; Brinch L; Remes K; Tidefelt U; Heilmann C; Hörnsten P; Thorling K; Daugaard G
    Leuk Lymphoma; 1996 Dec; 24(1-2):81-91. PubMed ID: 9049964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjuvant alpha-interferon improves complete remission rates following allogeneic transplantation for multiple myeloma.
    Byrne JL; Carter GI; Bienz N; Haynes AP; Russell NH
    Bone Marrow Transplant; 1998 Oct; 22(7):639-43. PubMed ID: 9818690
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of interferon tolerance after autologous bone marrow or peripheral blood stem cell transplants for myeloma patients who have responded to induction therapy.
    Powles R; Raje N; Horton C; Mehta J; Singhal S; Hickish T; Viner C; Milan S; Treleaven J; Cunningham D
    Leuk Lymphoma; 1996 May; 21(5-6):421-7. PubMed ID: 9172806
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation.
    Patriarca F; Carobolante F; Zamagni E; Montefusco V; Bruno B; Englaro E; Nanni C; Geatti O; Isola M; Sperotto A; Buttignol S; Stocchi R; Corradini P; Cavo M; Fanin R
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1068-73. PubMed ID: 25754658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Haematopoietic stem-cell transplantation in multiple myeloma.
    Handelsman H
    Cancer Treat Rev; 1996 Mar; 22(2):119-25. PubMed ID: 8665564
    [No Abstract]   [Full Text] [Related]  

  • 53. Transplantation in multiple myeloma.
    Topolsky D; Biggs D
    Semin Oncol; 1995 Jun; 22(3):230-7. PubMed ID: 7777867
    [No Abstract]   [Full Text] [Related]  

  • 54. [Multiple myeloma with oral amyloidosis: report of a case and literature review].
    Li N; Shang W; Yang XC; Song K
    Shanghai Kou Qiang Yi Xue; 2016 Oct; 25(5):638-640. PubMed ID: 28116444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complete remission following treatment with bortezomib, doxorubicin, dexamethasone and autologous stem cell transplant in patient with immunoglobulin E multiple myeloma.
    Pogłód R; Kraj M; Kruk B; Hagedorna-Tronina R; Łetowska M; Warzocha K
    Leuk Lymphoma; 2010 Dec; 51(12):2291-4. PubMed ID: 20929320
    [No Abstract]   [Full Text] [Related]  

  • 56. Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical Trial.
    Sanchorawala V; Brauneis D; Shelton AC; Lo S; Sun F; Sloan JM; Quillen K; Seldin DC
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1445-51. PubMed ID: 25858810
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Plasma-cell myeloma. II. New developments in the diagnosis and treatment of the disease].
    Barlogie B; Epstein J; Selvanayagam P; Alexanian R
    Gematol Transfuziol; 1992; 37(7-8):33-9. PubMed ID: 1342986
    [No Abstract]   [Full Text] [Related]  

  • 58. Three-step high-dose sequential chemotherapy in patients with newly diagnosed multiple myeloma.
    Ballestrero A; Ferrando F; Miglino M; Clavio M; Gonella R; Garuti A; Grasso R; Ghio R; Balleari E; Gobbi M; Patrone F
    Eur J Haematol; 2002 Feb; 68(2):101-6. PubMed ID: 12038448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prolonged survival after intensive therapy and purged ABMT in patients with multiple myeloma.
    Reece DE; Brockington DA; Phillips GL; Barnett MJ; Klingemann HG; Nantel SH; Sutherland HJ; Shepherd JD
    Bone Marrow Transplant; 2000 Sep; 26(6):621-6. PubMed ID: 11041567
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autologous transplantation for primary systemic AL amyloidosis is feasible outside a major amyloidosis referral centre: the Calgary BMT Program experience.
    Chow LQ; Bahlis N; Russell J; Chaudhry A; Morris D; Brown C; Stewart DA
    Bone Marrow Transplant; 2005 Oct; 36(7):591-6. PubMed ID: 16062177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.